Biotech Startup Zaara Biotech Bags Funding To Set Up Manufacturing Facility & Research Centres

SourceJaspreet Kaur
Date Published06/06/2022
Author NameJaspreet Kaur
Mentions specific company case(s) of reshoring, kept from offshoring, or transplantYes

Additional Reshoring Information:

Company/Division name Zaara Biotech USA
Parent companyZaara Biotech
Type of work Manufacturing
Reshoring category:Foreign Direct Investment
Year reshoring announced:2022
Domestically, the work will be done:In-house
Country(ies) from which reshored:India
If relevant, work nearshored to:-
Product(s) reshoredalgal seaweed technology
What non-domestic negative factors made offshoring less attractive?Green considerations
What domestic positive factors made reshoring more attractive?Eco-system synergies, Government Incentives, $10 Mn from the UAE-based TCN International Commer
Find Reshoring Articles